Following extensive consultation with health system partners, industry, healthcare professionals, academia and patients, we’re changing how topics are chosen (topic selection), the steps and stages in each evaluation (processes), and how evidence is collected and considered (methods) when assessing new medicines and other health technology products intended for use in the NHS. The changes will give patients earlier access to innovative new treatments by allowing greater flexibility over decisions about value for money and consideration of a broader evidence base. This new approach will come into effect for new submissions to NICE from 1 February.
|